Literature DB >> 29676596

Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.

Donna K Finch1, Valerie R Stolberg2, John Ferguson1, Henrih Alikaj2, Mohamed R Kady2, Bradley W Richmond3, Vasiliy V Polosukhin3, Timothy S Blackwell3,4,5,6, Lisa McCloskey7, Jeffrey L Curtis7,8,9, Christine M Freeman2,7,8.   

Abstract

RATIONALE: Lung natural killer cells (NKs) kill a greater percentage of autologous lung parenchymal cells in chronic obstructive pulmonary disease (COPD) than in nonobstructed smokers. To become cytotoxic, NKs require priming, typically by dendritic cells (DCs), but whether priming occurs in the lungs in COPD is unknown.
METHODS: We used lung tissue and in some cases peripheral blood from patients undergoing clinically indicated resections to determine in vitro killing of CD326+ lung epithelial cells by isolated lung CD56+ NKs. We also measured the cytotoxicity of unprimed blood NKs after preincubation with lung DCs. To investigate mechanisms of DC-mediated priming, we used murine models of COPD induced by cigarette smoke (CS) exposure or by polymeric immunoglobulin receptor (pIgR) deficiency, and blocked IL-15Rα (IL-15 receptor α subunit) trans-presentation by genetic and antibody approaches.
RESULTS: Human lung NKs killed isolated autologous lung epithelial cells; cytotoxicity was increased (P = 0.0001) in COPD, relative to smokers without obstruction. Similarly, increased lung NK cytotoxicity compared with control subjects was observed in CS-exposed mice and pIgR-/- mice. Blood NKs both from smokers without obstruction and subjects with COPD showed minimal epithelial cell killing, but in COPD, preincubation with lung DCs increased cytotoxicity. NKs were primed by CS-exposed murine DCs in vitro and in vivo. Inhibiting IL-15Rα trans-presentation eliminated NK priming both by murine CS-exposed DCs and by lung DCs from subjects with COPD.
CONCLUSIONS: Heightened NK cytotoxicity against lung epithelial cells in COPD results primarily from lung DC-mediated priming via IL-15 trans-presentation on IL-15Rα. Future studies are required to test whether increased NK cytotoxicity contributes to COPD pathogenesis.

Entities:  

Keywords:  chronic obstructive pulmonary disease; cigarette smoke; human; small-airway epithelial cells

Mesh:

Substances:

Year:  2018        PMID: 29676596      PMCID: PMC6221577          DOI: 10.1164/rccm.201712-2513OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  53 in total

1.  Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Authors:  Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Ready for prime time: NK cell priming by dendritic cells.

Authors:  Eric O Long
Journal:  Immunity       Date:  2007-04       Impact factor: 31.745

3.  Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study.

Authors:  A V Rogers; E Adelroth; K Hattotuwa; A Dewar; P K Jeffery
Journal:  Thorax       Date:  2007-09-17       Impact factor: 9.139

Review 4.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.

Authors:  Ingel K Demedts; Ken R Bracke; Geert Van Pottelberge; Dries Testelmans; Geert M Verleden; Frank E Vermassen; Guy F Joos; Guy G Brusselle
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

7.  Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2017-04-05       Impact factor: 79.321

8.  Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.

Authors:  Rima Koka; Patrick Burkett; Marcia Chien; Sophia Chai; David L Boone; Averil Ma
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells.

Authors:  Thuy Thanh Luu; Sridharan Ganesan; Arnika Kathleen Wagner; Dhifaf Sarhan; Stephan Meinke; Natalio Garbi; Günter Hämmerling; Evren Alici; Klas Kärre; Benedict J Chambers; Petter Höglund; Nadir Kadri
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

10.  Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.

Authors:  Bradley W Richmond; Robert M Brucker; Wei Han; Rui-Hong Du; Yongqin Zhang; Dong-Sheng Cheng; Linda Gleaves; Rasul Abdolrasulnia; Dina Polosukhina; Peter E Clark; Seth R Bordenstein; Timothy S Blackwell; Vasiliy V Polosukhin
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  19 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2018.

Authors:  Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

2.  Stem cell transplantation impairs dendritic cell trafficking and herpesvirus immunity.

Authors:  Carol A Wilke; Mathew M Chadwick; Paul R Chan; Bethany B Moore; Xiaofeng Zhou
Journal:  JCI Insight       Date:  2019-09-19

Review 3.  Tissue-resident innate immunity in the lung.

Authors:  Amanda Ardain; Mohlopheni J Marakalala; Alasdair Leslie
Journal:  Immunology       Date:  2019-11-21       Impact factor: 7.397

Review 4.  Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.

Authors:  Benedikt Jacobs; Veronika Gebel; Lukas Heger; Victoria Grèze; Hansjörg Schild; Diana Dudziak; Evelyn Ullrich
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

5.  Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking.

Authors:  Jonas Eriksson Ström; Jamshid Pourazar; Robert Linder; Anders Blomberg; Anne Lindberg; Anders Bucht; Annelie F Behndig
Journal:  Respir Res       Date:  2018-12-07

Review 6.  NK Cells in the Human Lungs.

Authors:  Baptiste Hervier; Jules Russick; Isabelle Cremer; Vincent Vieillard
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 7.  Natural Killer Cells in the Lungs.

Authors:  Jingjing Cong; Haiming Wei
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

8.  Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop Report.

Authors:  Robert M Tighe; Elizabeth F Redente; Yen-Rei Yu; Susanne Herold; Anne I Sperling; Jeffrey L Curtis; Ryan Duggan; Suchitra Swaminathan; Hideki Nakano; William J Zacharias; William J Janssen; Christine M Freeman; Ryan R Brinkman; Benjamin D Singer; Claudia V Jakubzick; Alexander V Misharin
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

9.  Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.

Authors:  Sergi Pascual-Guardia; Michelle Ataya; Isabel Ramírez-Martínez; José Yélamos; Roberto Chalela; Salomé Bellido; Miguel López-Botet; Joaquim Gea
Journal:  Respir Res       Date:  2020-03-04

10.  Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus.

Authors:  Grace E Cooper; Kristoffer Ostridge; Salim I Khakoo; Tom M A Wilkinson; Karl J Staples
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.